Friday, November 4, 2011

Patent case against Viacyte

After thinking about the conference call today, the strategic review at the end of this year should move the stock price higher. It was interesting that they keep on saying there would be no comments on forward movement. Why say this? Chip must be working on a deal or deals that will reduce the cash burn with big pharma and not want anyone to say anything to mess it up.
Good news I think in the patent case against on Viacyte. In the latest filing in the case the last paragraph. The parties have been negotiating a settlement. This could be big.

Good luck is this rigged casino,

No comments:

Post a Comment